First Time Loading...

Genetron Holdings Ltd
NASDAQ:GTH

Watchlist Manager
Genetron Holdings Ltd Logo
Genetron Holdings Ltd
NASDAQ:GTH
Watchlist
Price: 4.0201 USD 0% Market Closed
Updated: May 16, 2024

Wall Street
Price Targets

GTH Price Targets Summary
Genetron Holdings Ltd

Wall Street analysts forecast GTH stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GTH is 1.34 USD .

Lowest
Price Target
Not Available
Average
Price Target
1.34 USD
67% Downside
Highest
Price Target
Not Available
Genetron Holdings Ltd Competitors:
Price Targets
688520
Sinocelltech Group Ltd
49% Upside
BOLD
Boundless Bio Inc
168% Upside
HARP
Harpoon Therapeutics Inc
8% Upside
DVAX
Dynavax Technologies Corp
138% Upside
VCYT
Veracyte Inc
34% Upside
005690
Pharmicell Co Ltd
210% Upside
MDGL
Madrigal Pharmaceuticals Inc
82% Upside
PSTX
Poseida Therapeutics Inc
313% Upside

Revenue
Forecast

Revenue Estimate
Genetron Holdings Ltd

For the last 4 years the compound annual growth rate for Genetron Holdings Ltd's revenue is 30%. The projected CAGR for the next 2 years is 18%.

30%
Past Growth
18%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Genetron Holdings Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
15%
Average Beat

Net Income
Forecast

Net Income Estimate
Genetron Holdings Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
58%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GTH's stock price target?
Price Target
1.34 USD

According to Wall Street analysts, the average 1-year price target for GTH is 1.34 USD .

What is Genetron Holdings Ltd's Revenue forecast?
Projected CAGR
18%

For the last 4 years the compound annual growth rate for Genetron Holdings Ltd's revenue is 30%. The projected CAGR for the next 2 years is 18%.